The flagship company of the Piramal Group, Piramal Enterprises Ltd. (PEL), has business interests in Pharma, Information Management, and Financial Services verticals of the group.
Towards the late 80s, we shifted our focus from textile to pharmaceuticals. We chose to invest significantly in the domestic formulation development business, while other companies in the industry concentrated on international generics. Our efforts proved successful with a track record of approximately 23% revenue CAGR. In 2010, our strategy accomplished a sale of its domestic formulations business at an unprecedented value of ~9x sales and ~30x EBITDA.
In May 2013, we acquired a 10% equity stake in Shriram Transport Finance. This was followed by a 20% equity stake in Shriram Capital Limited, a financial services company, in April 2014. In June, 2014, we acquired an additional 9.9% stake in Shriram City Union Finance Limited, the retail focused Non-Banking Financial Company (NBFC) of the Shriram Group.
Our vision and work are a reflection of our core values - Knowledge, Action, Care and Impact; helping us develop and consolidate an international business network by partnering with global market leaders committed to creating long-term value.
Nurturing continuous innovation that fuels operational excellence
Delivering superior value to all our stakeholders
Fostering an environment where our employees thrive